Aim: Recessive genetic variation is thought to play a role in non-Hodgkin lymphoma (NHL) etiology. Runs of homozygosity (ROH), defined based on long, continuous segments of homozygous SNPs, can be used to estimate both measured and unmeasured recessive genetic variation. We sought to examine genome-wide homozygosity and NHL risk.

Methods: We used data from eight genome-wide association studies of four common NHL subtypes: 3061 chronic lymphocytic leukemia (CLL), 3814 diffuse large B-cell lymphoma (DLBCL), 2784 follicular lymphoma (FL), and 808 marginal zone lymphoma (MZL) cases, as well as 9374 controls. We examined the effect of homozygous variation on risk by: (1) estimating the fraction of the autosome containing runs of homozygosity (FROH); (2) calculating an inbreeding coefficient derived from the correlation among uniting gametes (F3); and (3) examining specific autosomal regions containing ROH. For each, we calculated beta coefficients and standard errors using logistic regression and combined estimates across studies using random-effects meta-analysis.

Results: We discovered positive associations between FROH and CLL (β = 21.1, SE = 4.41, P = 1.6 × 10^-6) and FL (β = 11.4, SE = 5.82, P = 0.02) but not DLBCL (P = 1.0) or MZL (P = 0.91). For F3, we observed an association with CLL (β = 27.5, SE = 6.51, P = 2.4 × 10^-5). We did not find evidence of associations with specific ROH, suggesting that the associations observed with FROH and F3 for CLL and FL risk were not driven by a single region of homozygosity.

Conclusion: Our findings support the role of recessive genetic variation in the etiology of CLL and FL; additional research is needed to identify the specific loci associated with NHL risk.

Journal of Translational Genetics and Genomics

Marketing and publicity strategies for launching the pilot phase of the Hong Kong Genome Project

Local causal pathway discovery for single-cell RNA sequencing count data: a benchmark study

Articles

The reactive stroma response regulates the immune landscape in prostate cancer

Duchenne muscular dystrophy: diagnosis and perspective of treatment

The potential therapeutic applications of long non-coding RNAs

Reduced protein kinase C delta in a high molecular weight complex in mitochondria and elevated creatine uptake into Barth syndrome B lymphoblasts

Challenges in determining the malignant potential of atypical neurofibromas (aNF) using histopathologic features and the potential need for CDKN2A/2B testing: a case report

The DNA damage response - from cell biology to human disease

Potentials and challenges of launching the pilot phase of Hong Kong Genome Project

Public and patient involvement in research to support genome services development in the UK

Topic: Genetic Diagnosis and Treatment of Duchenne Muscular Dystrophy

Topic: Genetic Susceptibility to Obesity-Related Complications--A Special Issue in Memory of Dr. Nathan A. Berger

Marketing and publicity strategies for launching the pilot phase of the Hong Kong Genome Project

Local causal pathway discovery for single-cell RNA sequencing count data: a benchmark study

Topic: Genetic Diagnosis and Treatment of Duchenne Muscular Dystrophy

Topic: Genetic Susceptibility to Obesity-Related Complications--A Special Issue in Memory of Dr. Nathan A. Berger

Special Interview with Prof. Yiping Shen

Journal of Translational Genetics and Genomics Receives a 2023 CiteScore of 2.7

Portico

Portico